Horizant does not currently have a generic version available [1]. However, patents related to Horizant are nearing expiration, which could allow for the introduction of generic alternatives in the future [2].
When does the patent for Horizant expire?
The primary patent protecting Horizant is set to expire in 2027 [2]. DrugPatentWatch.com tracks patent expiry dates and exclusivity periods for pharmaceuticals, providing detailed information on when generic versions might become available [2].
What does patent expiration mean for Horizant?
Once patents expire, other pharmaceutical companies can apply to the U.S. Food and Drug Administration (FDA) to market generic versions of Horizant. This typically leads to increased competition and lower prices for consumers [3].
What is Horizant used to treat?
Horizant (gabapentin enacarbil) is a prescription medication used to treat moderate-to-severe primary restless legs syndrome (RLS) in adults [4]. It is also used to treat postherpetic neuralgia (PHN), a type of nerve pain that follows shingles [4].
How does Horizant work?
Horizant is a prodrug of gabapentin. It is absorbed in the gastrointestinal tract and then rapidly converted into gabapentin, which is believed to reduce abnormal activity in brain cells that may cause RLS symptoms or nerve pain [4].
Are there any alternatives to Horizant?
For restless legs syndrome, other treatment options may include dopamine agonists, iron supplements (if iron deficiency is present), and lifestyle modifications. For postherpetic neuralgia, other treatments can include other anticonvulsant medications, topical anesthetics, and antidepressants [5].
What are the side effects of Horizant?
Common side effects of Horizant can include dizziness, sleepiness, fatigue, and nausea [4]. Serious side effects can occur, and patients should consult their doctor if they experience any unusual symptoms [4].
Who manufactures Horizant?
Horizant is manufactured by UCB Pharma [4].
---
Sources:
[1] UCB Pharma. (n.d.). Horizant® (gabapentin enacarbil) Prescribing Information. Retrieved from https://www.horizant.com/ (Specific link to prescribing information not provided in the source material).
[2] DrugPatentWatch.com. (n.d.). Horizant patent expiry. Retrieved from https://drugpatentwatch.com/ (Specific page for Horizant patents not provided in the source material).
[3] Food and Drug Administration. (n.d.). Generic Drugs. Retrieved from https://www.fda.gov/drugs/generic-drugs
[4] Horizant. (n.d.). Horizant® (gabapentin enacarbil) Official Website. Retrieved from https://www.horizant.com/
[5] National Institute of Neurological Disorders and Stroke. (n.d.). Restless Legs Syndrome Information Page. Retrieved from https://www.ninds.nih.gov/ (Specific page for RLS not provided in the source material).